Aðalfundur Alvotech S.A. boðaður 7. júní 2024
May 15, 2024 09:30 ET
|
Alvotech
Aðalfundur Alvotech S.A. verður haldinn föstudaginn 7. júní 2024, kl. 09.00 CEST á skrifstofu Arendt & Medernach S.A að 41A Avenue John F. Kennedy, L-1855 Lúxemborg. Drög af dagskrá fundarins er...
Alvotech S.A. Annual General Meeting to be held June 7, 2024
May 15, 2024 09:30 ET
|
Alvotech
The Annual General Meeting of Alvotech S.A. will be held on Friday June 7, 2024, at 09.00 a.m. CEST at the premises of Arendt & Medernach S.A. at 41A, Avenue John F. Kennedy L-1855 Luxembourg,...
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
May 14, 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, May 14, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Alvotech kynnir uppgjör fyrsta ársfjórðungs 2024 22. maí nk. kl. 12 að íslenskum tíma
May 13, 2024 08:00 ET
|
Alvotech
Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrsta ársfjórðungs 2024 eftir lokun markaða í Bandaríkjunum, þriðjudaginn 21. maí nk. Þá mun Alvotech halda kynningarfund fyrir...
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
May 13, 2024 08:00 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results...
Apnimed Named 2024 Best Places to Work Company by the Boston Business Journal
May 07, 2024 08:00 ET
|
Apnimed, Inc.
Apnimed Named 2024 Best Places to Work Company by the Boston Business Journal
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
May 06, 2024 07:15 ET
|
SAB Biotherapeutics, Inc.
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
BetterLife Announces Intent to Complete Private Placement of Units
May 03, 2024 18:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Alvotech tekur þátt í heilbrigðisráðstefnu BofA Securities í Bandaríkjunum
May 02, 2024 07:15 ET
|
Alvotech
Alvotech (NASDAQ: ALVO) tilkynnti í dag að félagið taki þátt í árlegri heilbrigðisráðstefnu BofA Securities, sem haldin verður dagana 14. – 15. maí í Las Vegas, Nevadafylki Bandaríkjanna. Fulltrúar úr...
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
May 02, 2024 07:15 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of management would be...